Mr. Immanuel Thangaraj is a Managing Director at Essex Woodlands Health Ventures, Inc.
He is on the Board of Directors at Acura Pharmaceuticals, Inc., Clear Vascular, Inc., Kona Medical, Inc., Proteus Digital Health, Inc. and TearScience, Inc.
Mr. Thangaraj was previously employed as a Portfolio Manager by ARCH Venture Partners LLC and Chairman by MAP International, Inc.
He also served on the board at CBR Systems, Inc., Medlogics Device Corp., PreCision Dermatology, Inc. and Sound ID Corp.
Mr. Thangaraj received his undergraduate degree from The University of Chicago and an MBA from The University of Chicago.